Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
AEMD Aethlon Medical, Inc. daily Stock Chart
AEMD [NASD]
Aethlon Medical, Inc.
Technology | Scientific & Technical Instruments | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.33 Insider Own1.30% Shs Outstand18.85M Perf Week-16.72%
Market Cap13.38M Forward P/E- EPS next Y-0.27 Insider Trans0.00% Shs Float17.78M Perf Month-29.00%
Income-5.90M PEG- EPS next Q-0.08 Inst Own15.00% Short Float3.33% Perf Quarter-49.29%
Sales0.20M P/S66.92 EPS this Y50.80% Inst Trans- Short Ratio5.12 Perf Half Y-38.26%
Book/sh0.18 P/B3.94 EPS next Y21.20% ROA-97.70% Target Price3.00 Perf Year-47.41%
Cash/sh0.25 P/C2.79 EPS next 5Y- ROE-125.10% 52W Range0.67 - 1.74 Perf YTD-57.23%
Dividend- P/FCF- EPS past 5Y22.40% ROI-75.50% 52W High-59.20% Beta0.93
Dividend %- Quick Ratio2.70 Sales past 5Y-34.40% Gross Margin- 52W Low5.97% ATR0.06
Employees6 Current Ratio2.70 Sales Q/Q- Oper. Margin- RSI (14)24.00 Volatility11.33% 6.84%
OptionableNo Debt/Eq0.27 EPS Q/Q-37.20% Profit Margin- Rel Volume1.89 Prev Close0.73
ShortableYes LT Debt/Eq0.00 EarningsMay 13 AMC Payout- Avg Volume115.80K Price0.71
Recom- SMA20-19.22% SMA50-28.22% SMA200-38.89% Volume218,526 Change-2.35%
Nov-20-17Initiated H.C. Wainwright Buy $3
Apr-17-19 08:27AM  Aethlon Medical Releases Shareholder Update PR Newswire
Apr-05-19 12:31PM  How Financially Strong Is Aethlon Medical, Inc. (NASDAQ:AEMD)? Simply Wall St.
Mar-07-19 08:47AM  Aethlon Medical, Inc. Announces Appointment of Lisa M. Boswell as Director, Quality Systems and Regulatory Affairs PR Newswire
Feb-13-19 03:45PM  AEMD: Eventual FDA Cancer Indication Is A Realistic Outcome Zacks Small Cap Research -21.67%
Feb-11-19 04:15PM  Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update PR Newswire
02:30PM  Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Feb-04-19 02:49PM  Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on February 11, 2019 PR Newswire
Jan-18-19 07:35AM  Market Trends Toward New Normal in Roper Technologies, The AES, D.R. Horton, Forrester Research, Aethlon Medical, and CyberOptics Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Dec-13-18 08:29AM  Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer PR Newswire
Nov-28-18 06:50AM  Todays Research Reports on Stocks to Watch: Arsanis and Aethlon Medical ACCESSWIRE
Nov-27-18 01:30PM  AEMD: Breakthrough Device Designation Granted for Cancer Therapy. Could Be Game-Changer for AEMD Zacks Small Cap Research +25.64%
10:10AM  The Reason Healthcare Stocks Are Being Called Home By Investors ACCESSWIRE
07:21AM  Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration PR Newswire
Nov-12-18 09:45AM  AEMD: Pivot Towards Cancer Makes Sense. FDA Filing For Breakthrough Device in Cancer Zacks Small Cap Research
08:15AM  Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-06-18 04:15PM  Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results PR Newswire
Nov-01-18 08:30AM  Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018 PR Newswire
Oct-29-18 11:59AM  Aethlon Medical to Present at the NYC Oncology Conference PR Newswire
Oct-18-18 09:25AM  Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire
Oct-16-18 08:15AM  Aethlon Medical to Present at the 2018 BIO Investor Forum PR Newswire
Oct-09-18 01:06PM  How Financially Strong Is Aethlon Medical Inc (NASDAQ:AEMD)? Simply Wall St.
Sep-18-18 08:46AM  Aethlon Medical Receives National Cancer Institute Award PR Newswire
Aug-28-18 09:15AM  AEMD: Compassionate Use, Real-World Data, Awaiting FDA Final Guidance Zacks Small Cap Research
Aug-27-18 08:00AM  Research Report Identifies Ball, Aethlon Medical, NeoGenomics, Del Taco Restaurants, Arconic, and Agilysys with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-08-18 04:15PM  Aethlon Medical Announces First Quarter Fiscal Year 2019 Results PR Newswire
02:30PM  Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:15AM  Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018 PR Newswire
Jun-27-18 09:15AM  Loss-Making Aethlon Medical Inc (NASDAQ:AEMD) Expected To Breakeven Simply Wall St.
Jun-25-18 09:15AM  Guy Cipriani Joins Aethlon Medical's Board of Directors PR Newswire
Jun-21-18 07:55AM  New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business Services, Veracyte, and TPG Specialty Lending Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-13-18 09:30AM  AEMD: AEMD In Active Discussions With FDA Regarding Hemopurifier Pathway Zacks Small Cap Research
Jun-08-18 04:15PM  Aethlon Medical Announces Fiscal 2018 Results PR Newswire +5.38%
May-31-18 08:45AM  Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018 PR Newswire
May-25-18 10:49AM  Are Aethlon Medical Incs (NASDAQ:AEMD) Interest Costs Too High? Simply Wall St.
May-01-18 07:55AM  Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-20-18 01:00PM  GVC Capital and Trickle Research Announce Presenter Schedule for Rocky Mountain MicroCap Conference II in Denver on April 24, 2018 ACCESSWIRE
Mar-22-18 08:00AM  Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix PR Newswire -7.09%
Mar-19-18 08:25AM  Research Report Identifies Chatham Lodging Trust (REIT), Independent Bank Group, NeoGenomics, Black Knight, Aethlon Medical, and PRA Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -11.05%
Feb-12-18 06:32AM  Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting PR Newswire +6.94%
Feb-06-18 10:00AM  AEMD: Q3 Results. Hemopurifier Pathway Could Benefit From New FDA Mindset Zacks Small Cap Research +9.28%
Feb-01-18 04:15PM  Aethlon Medical Announces Fiscal 2018 Third Quarter Results PR Newswire
Jan-29-18 08:15AM  Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018 PR Newswire +6.79%
Jan-23-18 08:15AM  Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes PR Newswire
Jan-19-18 06:05PM  Is It The Right Time To Buy Aethlon Medical Inc (NASDAQ:AEMD)? Simply Wall St.
Jan-18-18 07:49AM  Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections PR Newswire
Jan-17-18 08:15AM  Market Trends Toward New Normal in FTD Companies, Acuity Brands, MINDBODY, Actinium Pharmaceuticals, XG Technology, and Aethlon Medical Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-10-18 09:01AM  Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors PR Newswire
Jan-07-18 04:18PM  Aethlon Shares Jump Before '60 Minutes' Report On CTE, Vets Benzinga
Dec-27-17 07:55PM  How Does Aethlon Medical Incs (NASDAQ:AEMD) Earnings Growth Stack Up Against Industry Performance? Simply Wall St.
Nov-29-17 07:45AM  Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board PR Newswire
Nov-21-17 10:49AM  What Investors Should Know About Aethlon Medical Incs (AEMD) Financial Strength Simply Wall St.
Nov-09-17 12:58PM  Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors PR Newswire +10.82%
Nov-08-17 12:00PM  AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research -5.99%
Nov-02-17 04:15PM  Aethlon Medical Announces Fiscal 2018 Second Quarter Results PR Newswire
11:00AM  Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Oct-30-17 07:30AM  Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017 PR Newswire
Oct-23-17 08:00AM  AEMD: NCI Cancer Grant, FDAs Real World Data Zacks Small Cap Research
Oct-18-17 07:00AM  Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE
Oct-16-17 07:15AM  iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire
07:15AM  Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire
Oct-12-17 10:14AM  How Does Aethlon Medical Inc (AEMD)s Prospect Stack Up Next To Its Healthcare Peers? Simply Wall St.
Oct-11-17 08:15AM  Aethlon Medical to Present at the 2017 BIO Investor Forum PR Newswire
Oct-10-17 01:27PM  Aethlon Medical Announces Compliance With Nasdaq Listing Criteria PR Newswire
Oct-02-17 06:00AM  Aethlon Medical Announces Pricing of $6 Million Public Offering PR Newswire -37.66%
Sep-14-17 07:30AM  Aethlon Medical Receives National Cancer Institute Contract Award PR Newswire
Sep-13-17 08:20AM  Today's Research Reports on Stocks to Watch: Aldeyra Therapeutics and Aethlon Medical ACCESSWIRE -12.22%
Sep-12-17 07:30AM  Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses PR Newswire +35.13%
Sep-11-17 08:51PM  Should You Have Aethlon Medical Incs (AEMD) In Your Portfolio? Simply Wall St. +25.67%
Sep-06-17 09:12AM  Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017 PR Newswire +7.38%
Aug-21-17 10:00AM  AEMD: EAP Filed, Expect FDA Response By Mid-September Zacks Small Cap Research
Aug-11-17 09:02AM  Former NFL Pro Supports Study Of Brain Injuries And Dementia In Football Forbes
Aug-10-17 04:15PM  Aethlon Medical Announces Fiscal 2018 First Quarter Results PR Newswire -10.56%
01:00PM  Investor Network: Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 07:29PM  ETFs with exposure to Aethlon Medical, Inc. : August 3, 2017 Capital Cube
08:00AM  Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017 PR Newswire
Jul-19-17 07:11AM  Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes PR Newswire
Jul-07-17 07:00AM  Corporate News Blog - MedShape Divests its ExoShape(R) ACL Product Line to CONMED Accesswire
Jul-03-17 02:46PM  ETFs with exposure to Aethlon Medical, Inc. : July 3, 2017 Capital Cube
Jun-30-17 03:00PM  AEMD: Feasibility Study Validates Capture, EAP FDA Filing Is Next Zacks Small Cap Research
12:50PM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2017 By the Numbers : June 30, 2017 Capital Cube
Jun-28-17 04:15PM  Aethlon Medical Announces Fiscal 2017 Results PR Newswire +10.23%
Jun-26-17 08:15AM  Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017 PR Newswire
Jun-14-17 08:00AM  Aethlon Medical To Present Clinical Study Results at The BIO International Convention PR Newswire +50.00%
Jun-06-17 08:00AM  Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017 PR Newswire
May-24-17 08:00AM  Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017 PR Newswire -6.24%
Apr-28-17 11:00AM  AEMD: Feasibility Study Complete. FDA Discussions Expected To Follow Zacks Small Cap Research
Apr-24-17 09:25AM  Aethlon Medical Releases Shareholder Update PR Newswire
Apr-04-17 09:03AM  Aethlon Medical Discloses Tech Nation Interview On National Public Radio PR Newswire
09:03AM  Aethlon Medical Discloses Tech Nation Interview On National Public Radio
Mar-31-17 09:17AM  AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
Mar-21-17 02:50PM  AETHLON MEDICAL INC Files SEC form 8-K, Other Events
Mar-14-17 05:17PM  AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Mar-13-17 07:15AM  Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study PR Newswire
Mar-08-17 09:25AM  Aethlon Medical To Present At ROTH Capital Partners 29th Annual Growth Stock Conference On March 14, 2017 PR Newswire
Mar-01-17 09:25AM  Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes PR Newswire
Feb-24-17 09:25AM  Aethlon Medical CEO Note: Bill Gates on the Threat of Bioterrorism PR Newswire
Feb-22-17 09:25AM  Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies PR Newswire
Feb-16-17 01:04PM  AETHLON MEDICAL INC Financials
Feb-15-17 09:00AM  AEMD: FDA Discussions Regarding U.S. Clearance Pathway Zacks Small Cap Research
09:00AM  AEMD: FDA Discussions Regarding U.S. Clearance Pathway
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device that eliminates life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosomal biomarkers to diagnose and monitor life-threatening disease conditions, such as cancer and neurological disorders; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fink Benjamin MatthewEVP, Finance and CFOFeb 13Option Exercise0.00917020,119Feb 14 05:02 PM
REEVES ROBERT KEVPNov 14Option Exercise0.006,5040133,409Nov 16 05:02 PM
Champion Christopher OSVP, CAO and ControllerNov 14Option Exercise0.002,775013,809Nov 16 04:44 PM
WALKER R AChairman & CEONov 14Option Exercise0.0019,2510236,816Nov 16 04:35 PM
McMillian Amanda M.EVP and General CounselNov 14Option Exercise0.003,469019,615Nov 16 04:31 PM
Ingram Mitchell WEVP, Intl, DW & ExplorationNov 14Option Exercise0.007,718053,746Nov 16 04:27 PM
GWIN ROBERT GPresidentNov 14Option Exercise0.007,718074,243Nov 16 04:23 PM
Brown Daniel EEVP, US Onshore OperationsNov 14Option Exercise0.007,718029,307Nov 16 04:16 PM
WALKER R AChairman, President & CEONov 10Option Exercise0.0014,9510222,946Nov 14 05:29 PM
GWIN ROBERT GEVP, Finance & CFONov 10Option Exercise0.005,994069,357Nov 14 05:22 PM
Champion Christopher OSVP, CAO and ControllerNov 10Option Exercise0.002,020011,499Nov 14 05:17 PM
Brown Daniel EEVP, US Onshore OperationsNov 10Option Exercise0.003,098022,286Nov 14 05:12 PM
REEVES ROBERT KEVP and CAONov 10Option Exercise0.004,6740128,584Nov 14 05:07 PM
McMillian Amanda M.EVP and General CounselNov 10Option Exercise0.002,424016,705Nov 14 05:02 PM
Ingram Mitchell WEVP, Intl, DW & ExplorationNov 10Option Exercise0.005,994048,329Nov 14 04:30 PM
Ingram Mitchell WEVP, Intl, DW & ExplorationNov 01Option Exercise0.0019,936048,842Nov 05 04:33 PM
GWIN ROBERT GEVP, Finance & CFOOct 26Option Exercise0.005,375066,333Oct 30 05:23 PM
McMillian Amanda M.EVP and General CounselOct 26Option Exercise0.001,691014,662Oct 30 05:19 PM
Champion Christopher OSVP, CAO and ControllerOct 26Option Exercise0.001,69109,865Oct 30 05:15 PM
REEVES ROBERT KEVP and CAOOct 26Option Exercise0.004,1910125,512Oct 30 05:11 PM
WALKER R AChairman, President & CEOOct 26Option Exercise0.0013,4030213,118Oct 30 05:05 PM
Brown Daniel EEVP, US Onshore OperationsOct 26Option Exercise0.002,053019,649Oct 30 05:01 PM
Champion Christopher OSVP, CAO and ControllerJun 01Option Exercise0.001,49108,505Jun 05 04:54 PM
Leyendecker Ernest A. IIIEVPJun 01Option Exercise0.0021,675043,461Jun 05 04:43 PM
open in yahoo | open in reuters | open in google